Literature DB >> 8998131

Complex metabolic studies in postoperative patients.

J S Samra, L K Summers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 8998131      PMCID： PMC1190626          DOI： 10.1097/00000658-199701000-00026

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  11 in total

1.  Metabolic effects of recombinant human growth hormone: isotopic studies in the postabsorptive state and during total parenteral nutrition.

Authors:  R G Douglas; D A Humberstone; A Haystead; J H Shaw
Journal:  Br J Surg       Date:  1990-07       Impact factor: 6.939

2.  Urinary excretion and efflux from the leg of 3-methylhistidine before and after major surgical operation.

Authors:  M J Rennie; K Bennegård; E Edén; P W Emery; K Lundholm
Journal:  Metabolism       Date:  1984-03       Impact factor: 8.694

3.  Response of serum interleukin-6 in patients undergoing elective surgery of varying severity.

Authors:  A M Cruickshank; W D Fraser; H J Burns; J Van Damme; A Shenkin
Journal:  Clin Sci (Lond)       Date:  1990-08       Impact factor: 6.124

4.  Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion.

Authors:  P D Zenobi; S Graf; H Ursprung; E R Froesch
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

5.  Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man.

Authors:  E Späth-Schwalbe; J Born; H Schrezenmeier; S R Bornstein; P Stromeyer; S Drechsler; H L Fehm; F Porzsolt
Journal:  J Clin Endocrinol Metab       Date:  1994-10       Impact factor: 5.958

6.  Anabolic therapy with growth hormone accelerates protein gain in surgical patients requiring nutritional rehabilitation.

Authors:  T A Byrne; T B Morrissey; C Gatzen; K Benfell; T V Nattakom; M R Scheltinga; M S LeBoff; T R Ziegler; D W Wilmore
Journal:  Ann Surg       Date:  1993-10       Impact factor: 12.969

7.  Administration of human recombinant insulin-like growth factor-I to patients following major gastrointestinal surgery.

Authors:  J P Miell; A M Taylor; J Jones; C R Buchanan; J Rennie; R Sherwood; R Leicester; R J Ross
Journal:  Clin Endocrinol (Oxf)       Date:  1992-12       Impact factor: 3.478

8.  Endocrinologic and metabolic effects of interleukin-6 in humans.

Authors:  J M Stouthard; J A Romijn; T Van der Poll; E Endert; S Klein; P J Bakker; C H Veenhof; H P Sauerwein
Journal:  Am J Physiol       Date:  1995-05

9.  Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I.

Authors:  R Ross; J Miell; E Freeman; J Jones; D Matthews; M Preece; C Buchanan
Journal:  Clin Endocrinol (Oxf)       Date:  1991-07       Impact factor: 3.478

10.  Repeated administration of recombinant human insulin-like growth factor-I in patients after gastric surgery. Effect on metabolic and hormonal patterns.

Authors:  C Goeters; N Mertes; J Tacke; U Bolder; M Kuhmann; P Lawin; D Löhlein
Journal:  Ann Surg       Date:  1995-11       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.